Celyad proposes follow-on

Celyad S.A. (Euronext:CYAD), Mont-Saint-Guibert, Belgium Business: Gene/Cell therapy, Cardiovascular, Cancer Date announced: 2015-05-18 Type: Follow-on To be raised: Up to $115 million Shares: TBD Pri...